A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy.
Charlotte Gotthard MortzLouise ParkeHelene M RasmussenHenrik Fomsgaard KjaerCarsten Bindslev-JensenPublished in: Allergy (2024)
An increase in the threshold level during Omalizumab treatment significantly improve patient safety and protected all children against small amount of allergen.